Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma

Takuji Okusaka, Shuichi Okada, Hideki Ueno, Masafumi Ikeda, Masayoshi Yoshimori, Kazuaki Shimada, Junji Yamamoto, Tomoo Kosuge, Susumu Yamasaki, Ryoko Iwata, Hiroyoshi Furukawa, Noriyuki Moriyama, Michiie Sakamoto, Setsuo Hirohashi

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Transcatheter arterial embolization (TAE) has been widely performed for patients with hepatocellular carcinoma (HCC). However, the method of evaluating the therapeutic effect of TAE has not been established. We examined the rate of necrotic area to whole tumor (TN) by CT, the tumor regression rate (TR) and the reduction rate in serum α-fetoprotein (AFP) levels in patients with HCC who received hepatic resection within 3 months after TAE. In the evaluation of TN, the lipiodol accumulation in tumor was regarded as being necrotic. Rates of necrotic area, which were also examined pathologically (PN) in resected tumors, were compared with TN, TR and AFP reduction rates, respectively. Eighty-eight patients were enrolled in this study, and there was a significant positive correlation between TN and PN (r = 0.80, p < 0.001). Although TR significantly correlated to PN (p = 0.001), the correlation coefficient between them was low (r = 0.34). The correlation coefficients between AFP reduction rate and PN was 0.76 (p < 0.001) in 26 patients (30%) with an AFP level ≥ 200 ng/ml before TAE. The evaluation method using lipiodol accumulation in CT is the most useful for assessing the therapeutic effect of TAE, particularly when a sufficiently long interval exists between TAE and the evaluation, because of the highest correlation coefficient between TN and PN, and the availability of TN for all patients. The reduction rate in serum AFP levels was also useful in patients with AFP levels > 200 ng/ml before treatment. Copyright (C) 2000 S. Karger AG, Basel.

Original languageEnglish
Pages (from-to)293-299
Number of pages7
JournalOncology
Volume58
Issue number4
Publication statusPublished - 2000 May
Externally publishedYes

Fingerprint

Therapeutic Uses
Hepatocellular Carcinoma
Neoplasms
Fetal Proteins
Ethiodized Oil
Liver
Serum

Keywords

  • α-fetoprotein
  • Hepatocellular carcinoma
  • Lipiodol accumulation
  • Transcatheter arterial embolization
  • Tumor necrosis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Okusaka, T., Okada, S., Ueno, H., Ikeda, M., Yoshimori, M., Shimada, K., ... Hirohashi, S. (2000). Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma. Oncology, 58(4), 293-299.

Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma. / Okusaka, Takuji; Okada, Shuichi; Ueno, Hideki; Ikeda, Masafumi; Yoshimori, Masayoshi; Shimada, Kazuaki; Yamamoto, Junji; Kosuge, Tomoo; Yamasaki, Susumu; Iwata, Ryoko; Furukawa, Hiroyoshi; Moriyama, Noriyuki; Sakamoto, Michiie; Hirohashi, Setsuo.

In: Oncology, Vol. 58, No. 4, 05.2000, p. 293-299.

Research output: Contribution to journalArticle

Okusaka, T, Okada, S, Ueno, H, Ikeda, M, Yoshimori, M, Shimada, K, Yamamoto, J, Kosuge, T, Yamasaki, S, Iwata, R, Furukawa, H, Moriyama, N, Sakamoto, M & Hirohashi, S 2000, 'Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma', Oncology, vol. 58, no. 4, pp. 293-299.
Okusaka T, Okada S, Ueno H, Ikeda M, Yoshimori M, Shimada K et al. Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma. Oncology. 2000 May;58(4):293-299.
Okusaka, Takuji ; Okada, Shuichi ; Ueno, Hideki ; Ikeda, Masafumi ; Yoshimori, Masayoshi ; Shimada, Kazuaki ; Yamamoto, Junji ; Kosuge, Tomoo ; Yamasaki, Susumu ; Iwata, Ryoko ; Furukawa, Hiroyoshi ; Moriyama, Noriyuki ; Sakamoto, Michiie ; Hirohashi, Setsuo. / Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma. In: Oncology. 2000 ; Vol. 58, No. 4. pp. 293-299.
@article{c28c8317f3b243d1ac3b6ae41ff263d9,
title = "Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma",
abstract = "Transcatheter arterial embolization (TAE) has been widely performed for patients with hepatocellular carcinoma (HCC). However, the method of evaluating the therapeutic effect of TAE has not been established. We examined the rate of necrotic area to whole tumor (TN) by CT, the tumor regression rate (TR) and the reduction rate in serum α-fetoprotein (AFP) levels in patients with HCC who received hepatic resection within 3 months after TAE. In the evaluation of TN, the lipiodol accumulation in tumor was regarded as being necrotic. Rates of necrotic area, which were also examined pathologically (PN) in resected tumors, were compared with TN, TR and AFP reduction rates, respectively. Eighty-eight patients were enrolled in this study, and there was a significant positive correlation between TN and PN (r = 0.80, p < 0.001). Although TR significantly correlated to PN (p = 0.001), the correlation coefficient between them was low (r = 0.34). The correlation coefficients between AFP reduction rate and PN was 0.76 (p < 0.001) in 26 patients (30{\%}) with an AFP level ≥ 200 ng/ml before TAE. The evaluation method using lipiodol accumulation in CT is the most useful for assessing the therapeutic effect of TAE, particularly when a sufficiently long interval exists between TAE and the evaluation, because of the highest correlation coefficient between TN and PN, and the availability of TN for all patients. The reduction rate in serum AFP levels was also useful in patients with AFP levels > 200 ng/ml before treatment. Copyright (C) 2000 S. Karger AG, Basel.",
keywords = "α-fetoprotein, Hepatocellular carcinoma, Lipiodol accumulation, Transcatheter arterial embolization, Tumor necrosis",
author = "Takuji Okusaka and Shuichi Okada and Hideki Ueno and Masafumi Ikeda and Masayoshi Yoshimori and Kazuaki Shimada and Junji Yamamoto and Tomoo Kosuge and Susumu Yamasaki and Ryoko Iwata and Hiroyoshi Furukawa and Noriyuki Moriyama and Michiie Sakamoto and Setsuo Hirohashi",
year = "2000",
month = "5",
language = "English",
volume = "58",
pages = "293--299",
journal = "Oncology (Switzerland)",
issn = "0030-2414",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma

AU - Okusaka, Takuji

AU - Okada, Shuichi

AU - Ueno, Hideki

AU - Ikeda, Masafumi

AU - Yoshimori, Masayoshi

AU - Shimada, Kazuaki

AU - Yamamoto, Junji

AU - Kosuge, Tomoo

AU - Yamasaki, Susumu

AU - Iwata, Ryoko

AU - Furukawa, Hiroyoshi

AU - Moriyama, Noriyuki

AU - Sakamoto, Michiie

AU - Hirohashi, Setsuo

PY - 2000/5

Y1 - 2000/5

N2 - Transcatheter arterial embolization (TAE) has been widely performed for patients with hepatocellular carcinoma (HCC). However, the method of evaluating the therapeutic effect of TAE has not been established. We examined the rate of necrotic area to whole tumor (TN) by CT, the tumor regression rate (TR) and the reduction rate in serum α-fetoprotein (AFP) levels in patients with HCC who received hepatic resection within 3 months after TAE. In the evaluation of TN, the lipiodol accumulation in tumor was regarded as being necrotic. Rates of necrotic area, which were also examined pathologically (PN) in resected tumors, were compared with TN, TR and AFP reduction rates, respectively. Eighty-eight patients were enrolled in this study, and there was a significant positive correlation between TN and PN (r = 0.80, p < 0.001). Although TR significantly correlated to PN (p = 0.001), the correlation coefficient between them was low (r = 0.34). The correlation coefficients between AFP reduction rate and PN was 0.76 (p < 0.001) in 26 patients (30%) with an AFP level ≥ 200 ng/ml before TAE. The evaluation method using lipiodol accumulation in CT is the most useful for assessing the therapeutic effect of TAE, particularly when a sufficiently long interval exists between TAE and the evaluation, because of the highest correlation coefficient between TN and PN, and the availability of TN for all patients. The reduction rate in serum AFP levels was also useful in patients with AFP levels > 200 ng/ml before treatment. Copyright (C) 2000 S. Karger AG, Basel.

AB - Transcatheter arterial embolization (TAE) has been widely performed for patients with hepatocellular carcinoma (HCC). However, the method of evaluating the therapeutic effect of TAE has not been established. We examined the rate of necrotic area to whole tumor (TN) by CT, the tumor regression rate (TR) and the reduction rate in serum α-fetoprotein (AFP) levels in patients with HCC who received hepatic resection within 3 months after TAE. In the evaluation of TN, the lipiodol accumulation in tumor was regarded as being necrotic. Rates of necrotic area, which were also examined pathologically (PN) in resected tumors, were compared with TN, TR and AFP reduction rates, respectively. Eighty-eight patients were enrolled in this study, and there was a significant positive correlation between TN and PN (r = 0.80, p < 0.001). Although TR significantly correlated to PN (p = 0.001), the correlation coefficient between them was low (r = 0.34). The correlation coefficients between AFP reduction rate and PN was 0.76 (p < 0.001) in 26 patients (30%) with an AFP level ≥ 200 ng/ml before TAE. The evaluation method using lipiodol accumulation in CT is the most useful for assessing the therapeutic effect of TAE, particularly when a sufficiently long interval exists between TAE and the evaluation, because of the highest correlation coefficient between TN and PN, and the availability of TN for all patients. The reduction rate in serum AFP levels was also useful in patients with AFP levels > 200 ng/ml before treatment. Copyright (C) 2000 S. Karger AG, Basel.

KW - α-fetoprotein

KW - Hepatocellular carcinoma

KW - Lipiodol accumulation

KW - Transcatheter arterial embolization

KW - Tumor necrosis

UR - http://www.scopus.com/inward/record.url?scp=0034071842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034071842&partnerID=8YFLogxK

M3 - Article

C2 - 10838494

AN - SCOPUS:0034071842

VL - 58

SP - 293

EP - 299

JO - Oncology (Switzerland)

JF - Oncology (Switzerland)

SN - 0030-2414

IS - 4

ER -